Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New ideas for treating hypertension

¹Department of Clinical Pharmacology, St Mary's Hospital, London, UK.

Journal of Human Hypertension

|August 1, 1995

Summary

This summary is machine-generated.

New antihypertensive drug classes are in development due to patient non-response and market demand. This review covers novel agents like angiotensin receptor antagonists and renin inhibitors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Morphology assessment and fluorescence in situ hybridization of the same spermatozoon using a computerized cell-scanning system.

Human reproduction (Oxford, England)·2006

Same author

Meiotic arrest in vitro by phosphodiesterase 3-inhibitor enhances maturation capacity of human oocytes and allows subsequent embryonic development.

Biology of reproduction·2005

Same author

The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice: position statement of a United Kingdom consensus panel.

Current medical research and opinion·2005

Same author

The outcome of ICSI of immature MI oocytes and rescued in vitro matured MII oocytes.

Human reproduction (Oxford, England)·2004

Same author

Antihypertensive efficacy of moxonidine in primary care: a 'real-life' study.

International journal of clinical practice·2003

Same author

Coasting-what is the best formula?

Human reproduction (Oxford, England)·2003

Same journal

Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.

Journal of human hypertension·2026

Same journal

Invasive observation of reactive systolic blood pressure responses to upper-arm cuff inflation.

Journal of human hypertension·2026

Same journal

Association between post-thrombectomy blood pressure trajectories and clinical outcomes in hypertensive patients with acute ischemic stroke: a retrospective cohort study.

Journal of human hypertension·2026

Same journal

Systemic inflammation indices generated from first-trimester blood tests can be potential biomarkers for predicting preeclampsia.

Journal of human hypertension·2026

Same journal

Chronotherapy in hypertension: a systematic review and meta-analysis of antihypertensive dosing timing on cardiovascular outcomes.

Journal of human hypertension·2026

Same journal

Effect of relative handgrip strength and back muscle strength on the incidence of hypertension: 18-year follow-up in a population-based cohort study.

Journal of human hypertension·2026

See all related articles

Area of Science:

Pharmacology
Cardiovascular Medicine

Background:

Existing antihypertensive medications are insufficient for some patients.
Hypertension is a significant global health concern and market.

Purpose of the Study:

To review emerging classes of antihypertensive agents.
To discuss their potential clinical significance.

Main Methods:

Review of scientific literature on novel antihypertensive drug classes.
Categorization of agents by mechanism of action and development stage.

Main Results:

Several novel drug classes are under development, including AT1 receptor antagonists, renin inhibitors, imidazoline receptor agonists, potassium channel openers, neutral endopeptidase inhibitors, and endothelin antagonists.

Related Experiment Videos

Some agents are nearing market, while others remain in preclinical stages.

Conclusions:

Novel antihypertensive drugs offer potential solutions for treatment-resistant hypertension.
Continued research and development are crucial for addressing unmet needs in hypertension management.